RxSight, Inc. — Director's Dealing 2025

Mar 13, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RxSight, Inc. (RXST)
CIK: 0001111485
Period of Report: 2025-03-12

Reporting Person: Fountain Tamara (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-12	Common Stock	S	7000	$25.7145	Disposed	24793	Direct

Footnotes

F1: The sales reported were effected pursuant to a Rule 10b5-1 trading plan established on December 11, 2024 by the Reporting Person.

F2: Represents the weighted average share price of an aggregate total of 7,000 shares sold in the price range of $25.355 to $26.175 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.